AU Stock MarketDetailed Quotes

HPC The Hydration Pharmaceuticals Co Ltd

Watchlist
  • 0.009
  • 0.0000.00%
20min DelayMarket Closed Jul 4 11:30 AET
2.74MMarket Cap-152P/E (Static)

The Hydration Pharmaceuticals Co Ltd Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 30, 2023
(FY)Dec 30, 2022
(FY)Dec 30, 2021
Operating cash flow (direct method)
Cash income from operating activities
10.89%9.6M
61.82%8.66M
5.35M
Revenue from customers
9.00%9.6M
48.05%8.81M
--5.95M
Other cash income from operating activities
----
74.93%-150.16K
---598.85K
Cash paid
19.59%-14.8M
-37.09%-18.41M
-13.43M
Payments to suppliers for goods and services
19.59%-14.8M
-37.09%-18.41M
---13.43M
Direct interest paid
---527.8K
----
----
Operating cash flow
41.24%-5.73M
-20.72%-9.75M
---8.08M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-33.37%2.72M
-76.06%4.08M
17.03M
Net issuance payments of debt
----
-36.46%4.08M
--6.42M
Net common stock issuance
--2.72M
----
--12.03M
Net other financing activities
----
----
---1.42M
Cash from discontinued financing activities
Financing cash flow
-33.37%2.72M
-76.06%4.08M
--17.03M
Net cash flow
Beginning cash position
-56.07%4.69M
548.95%10.67M
--1.64M
Current changes in cash
46.90%-3.01M
-163.43%-5.68M
--8.95M
Effect of exchange rate changes
153.90%166.2K
-491.18%-308.35K
--78.82K
End cash Position
-60.75%1.84M
-56.07%4.69M
--10.67M
Free cash from
41.24%-5.73M
-20.72%-9.75M
---8.08M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
(FY)Dec 30, 2023(FY)Dec 30, 2022(FY)Dec 30, 2021
Operating cash flow (direct method)
Cash income from operating activities 10.89%9.6M61.82%8.66M5.35M
Revenue from customers 9.00%9.6M48.05%8.81M--5.95M
Other cash income from operating activities ----74.93%-150.16K---598.85K
Cash paid 19.59%-14.8M-37.09%-18.41M-13.43M
Payments to suppliers for goods and services 19.59%-14.8M-37.09%-18.41M---13.43M
Direct interest paid ---527.8K--------
Operating cash flow 41.24%-5.73M-20.72%-9.75M---8.08M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -33.37%2.72M-76.06%4.08M17.03M
Net issuance payments of debt -----36.46%4.08M--6.42M
Net common stock issuance --2.72M------12.03M
Net other financing activities -----------1.42M
Cash from discontinued financing activities
Financing cash flow -33.37%2.72M-76.06%4.08M--17.03M
Net cash flow
Beginning cash position -56.07%4.69M548.95%10.67M--1.64M
Current changes in cash 46.90%-3.01M-163.43%-5.68M--8.95M
Effect of exchange rate changes 153.90%166.2K-491.18%-308.35K--78.82K
End cash Position -60.75%1.84M-56.07%4.69M--10.67M
Free cash from 41.24%-5.73M-20.72%-9.75M---8.08M
Accounting Standards US-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
%Chg